Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-07

Clinical Trial Update: Esketamine Combined With Pregabalin on CPSP in Spinal Patients. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is examining esketamine combined with pregabalin for chronic post-operative pain after spinal surgery; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Esketamine, Pregabaline | Phase 2, Phase 3 | Status: UNKNOWN